Voluntary nanotech code of conduct should stir EU parties into action
This article was originally published in Clinica
The European Commission is inviting member states to take concrete action - involving universities, research institutes and companies - to ensure the safe development and use of nanotechnologies, including nanomedtech products, by issuing a code of conduct to govern research in this field.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.